The present invention relates to a pharmaceutical composition for oral administration containing coagulation factor VIII or IX. More particularly, it relates to a novel pharmaceutical composition suitable for the treatment or prophylaxis of hemophilia A or B by oral administration, which comprises
CROSS REFERENCE TO A RELATED APPLICATION
This application is a National Stage Application of International Application Number PCT/EP2009/005465, filed Jul. 28, 2009; which claims priority to European Application No. 08013561.9, filed Jul. 28, 2008; which are incorporated herein by reference in their
This application is based upon provisional application Ser. No. 60/018,874, filed May 29,1996.
FIELD OF THE INVENTION
The present invention relates to a process for producing recombinant human proteins and polypeptides, and a cell culture medium for use in said production. More particularly, the
All documents cited in this disclosure are incorporated herein by reference in their entireties.
This application incorporates by reference a 64 kb text file created on Mar. 26, 2012 and named "0297301274sequencelisting.txt," which is the sequence listing for this application.
TECHNICAL FIELD
The
اكتب أحد الأعراض أو المرض واقرأ عن الأعشاب التي قد تساعد ، واكتب عشبًا واطلع على الأمراض والأعراض التي تستخدم ضدها. * تستند جميع المعلومات إلى البحوث العلمية المنشورة